In the present study, we examined the prognostic impact of the pre-treatment plasma CRP level in patients with locally advanced rectal cancer treated with nRCT and detected a significant relationship between an elevated pre-treatment CRP level and a decreased RFS, LC, MFS, and OS in univariate and multivariate analysis. This evidence concerns the gene CRP and rectal cancer.